Key Events This Week
Jan 19: New 52-week and all-time low at Rs.4,017
Jan 20: Further decline to Rs.3,967, marking fresh 52-week and all-time lows
Jan 21: Price recovery to Rs.4,084.90 (+0.97%)
Jan 23: Week closes at Rs.4,064.00 (-0.81%)
Jan 28
BSE+NSE Vol: 1.94 k
Jan 19: New 52-week and all-time low at Rs.4,017
Jan 20: Further decline to Rs.3,967, marking fresh 52-week and all-time lows
Jan 21: Price recovery to Rs.4,084.90 (+0.97%)
Jan 23: Week closes at Rs.4,064.00 (-0.81%)
Sanofi Consumer Healthcare India Ltd’s stock declined to a fresh 52-week low of Rs.3967 on 20 Jan 2026, marking a significant downturn amid a broader market correction. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on valuation and profitability metrics.
Read full news articleSanofi Consumer Healthcare India Ltd’s share price has fallen to a new all-time low of Rs. 3,967, marking a significant downturn amid sustained negative returns and underperformance relative to key market indices and sector peers.
Read full news articleSanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleSanofi Consumer Healthcare India Ltd’s stock declined to a fresh 52-week low of Rs.4017 on 19 Jan 2026, marking a significant milestone in its recent price trajectory amid broader market fluctuations and company-specific performance factors.
Read full news articleSanofi Consumer Healthcare India Ltd’s stock reached a new all-time low of Rs. 4,017 on 19 Jan 2026, marking a significant milestone in its ongoing decline. Despite a slight rebound today, the stock remains under pressure, reflecting a challenging period for the company within the Pharmaceuticals & Biotechnology sector.
Read full news article
Recent Price Movements and Market Performance
Sanofi Consumer Healthcare’s stock has been under pressure, hitting a new 52-week and all-time low of ₹4,270 during intraday trading on 12-Jan. Despite an intraday high of ₹4,470, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. The stock has declined for three consecutive days, losing 3.74% over this period, and underperformed its sector by 1.34% on the day.
Further technical indicators reinforce the bearish sentiment, with the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness often deters short-term investors and can exacerbate downward momentum.
Sanofi Consumer Healthcare India Ltd’s stock declined to a fresh 52-week low of Rs 4,285 on 9 Jan 2026, marking a significant price level that reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector. The stock has underperformed both its sector and broader market indices over the past year, signalling a period of subdued investor sentiment and valuation adjustments.
Read full news articleSanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleNo Upcoming Board Meetings
Sanofi Consumer Healthcare India Ltd has declared 550% dividend, ex-date: 17 Apr 25
No Splits history available
No Bonus history available
No Rights history available